About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a company based in Victoria (Canada) founded in 1989. The company has 102 employees as of April 30, 2024. ImmunoPrecise Antibodies offers products and services including Antibody Discovery Services, Protein Production, LENS ai, and Online Store. ImmunoPrecise Antibodies operates in a competitive market with competitors including Abcam, Pharmaron, Lonza, Pfizer and Boehringer Ingelheim, among others.
- Headquarter Victoria, Canada
- Employees 102 as on 30 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Immunoprecise Antibodies Ltd.
-
Annual Revenue
$17.6 M (USD)-3.09as on Apr 30, 2025
-
Net Profit
-$21.7 M (USD)-12.18as on Apr 30, 2025
-
EBITDA
-$5.21 M (USD)15.87as on Apr 30, 2025
-
Latest Funding Round
$2 M (USD), Post-IPO
Jul 16, 2024
-
Investors
State of North Dakota
& 2 more
-
Employee Count
102
as on Apr 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a publicly listed company on the NASDAQ with ticker symbol HYFT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of ImmunoPrecise Antibodies
ImmunoPrecise Antibodies offers a comprehensive portfolio of products and services, including Antibody Discovery Services, Protein Production, LENS ai, and Online Store.
Services for antibody analysis, immunization, and characterization in research.
Production of proteins and catalog products for biotherapeutic applications.
AI platform for analyzing biotherapeutic data and improving decision-making.
Platform selling protein products and growth factors for research needs.
Funding Insights of ImmunoPrecise Antibodies
Investors in ImmunoPrecise Antibodies
ImmunoPrecise Antibodies has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include State of North Dakota, Brisio Innovations and Yorkville Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Offline focused VC firm investing in companies primarily in Canada
|
Locked | Locked | Locked | |
|
Government information and state agencies are provided for North Dakota.
|
Locked | Locked | Locked | |
|
Offers flexible capital to micro-cap and small-cap firms for growth.
|
Locked | Locked | Locked |
Investor details for ImmunoPrecise Antibodies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ImmunoPrecise Antibodies
Investment portfolio details for ImmunoPrecise Antibodies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ImmunoPrecise Antibodies
Detailed financials for ImmunoPrecise Antibodies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immunoprecise Antibodies Comparisons
Peer comparison for ImmunoPrecise Antibodies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ImmunoPrecise Antibodies
ImmunoPrecise Antibodies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Pharmaron, Lonza, Pfizer and Boehringer Ingelheim, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Drug discovery and development services for small molecules are provided.
|
|
| Locked | Locked | Locked |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| Locked | Locked | Locked |
Generic drugs and clinical research services are provided globally.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
Detailed competitors of ImmunoPrecise Antibodies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immunoprecise Antibodies
Complete news archive for ImmunoPrecise Antibodies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ImmunoPrecise Antibodies
ImmunoPrecise Antibodies was founded in 1989 and raised its 1st funding round 27 years after it was founded.
ImmunoPrecise Antibodies is headquartered in Victoria, Canada. It is registered at Victoria, British Columbia, Canada.
As of Apr 30, 2024, the latest employee count at ImmunoPrecise Antibodies is 102.
Annual revenue of ImmunoPrecise Antibodies is $17.6M as on Apr 30, 2025.
ImmunoPrecise Antibodies was founded in 1989 and is headquartered in Victoria, Canada. Operations are centered in the biotechnology sector, where contract development and manufacturing services are provided for antibody-based therapeutics. Focus is placed on antibody discovery platforms and pre-clinical development, supporting clients from early research through to validation stages. Expertise is applied in custom antibody production and related assays, serving global pharmaceutical and biotech partners.
ImmunoPrecise Antibodies offers Antibody Discovery Services, Protein Production, LENS ai, and Online Store.
Yes, ImmunoPrecise Antibodies is publicly traded on NASDAQ under the ticker symbol HYFT.
ImmunoPrecise Antibodies has 3 investors. Key investors include State of North Dakota, Brisio Innovations, and Yorkville Advisors.
The ticker symbol of ImmunoPrecise Antibodies is HYFT on NASDAQ.